Pharmacology

Action Mechanism of Action Reference
RNAI INHIBITOR Transthyretin mRNA RNAi inhibitor FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Amyloidosis 3 D000686 ClinicalTrials
Amyloid Neuropathies, Familial 3 D028227 ClinicalTrials

Related Entries

Salt

Cross References

Resources Reference
CAS NUMBER 1420706-45-1
ChEMBL CHEMBL3989987
FDA SRS 50FKX8CB2Y